Table 4 RHAMM immunostaining patterns shown in primary and metastatic tumors
From: Increased RHAMM expression relates to ovarian cancer progression
Patient | Description | Grade | Staining | % Staining | Intensity |
|---|---|---|---|---|---|
P1 | Normal Ovary | – | – | 0 | Negative |
P1 | Primary OC | low | + | 1 | Weak |
P1 | Omental metastasis | low | + | 1 | Weak |
P2 | Primary OC | low | + | 2 | Weak |
P2 | Omental metastasis | low | + | 2 | Weak |
P3 | Normal Ovary | – | – | 0 | Negative |
P3 | Primary OC | high | + | 3 | Strong |
P3 | Omental metastasis | high | + | 3 | Moderate |
P4 | Primary OC | high | + | 1 | Weak |
P4 | Omental metastasis | high | + | 1 | Weak |
P5 | Primary OC | high | – | 0 | Negative |
P5 | Omental metastasis | high | – | 0 | Negative |
P6 | Primary OC | high | + | 3 | Strong |
P6 | Omental metastasis | high | + | 3 | Strong |
P7 | Primary OC | high | + | 2 | Moderate |
P7 | Omental metastasis | high | + | 2 | Moderate |
P8 | Primary OC | high | + | 2 | Moderate |
P8 | Lymph node metastasis | high | + | 1 | Weak |